New cases come from SEER 12. Deaths come from U.S. Mortality. All Races, Both Sexes. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Age-Adjusted Rates of New Cases/Deaths Per 100,000 & 5-Year Relative Survival Percentages
Year
Rate of New Cases — SEER 8
Rate of New Cases — SEER 12
Death Rate — U.S.
5-Year Relative Survival — SEER 8
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
Observed
Modeled Trend
1975
11.88
11.74
-
-
10.64
10.70
3.18%
1.86%
1976
11.80
11.70
-
-
10.66
10.70
2.28%
1.93%
1977
11.90
11.65
-
-
10.85
10.70
1.45%
2.00%
1978
10.85
11.61
-
-
10.78
10.69
2.49%
2.08%
1979
11.37
11.57
-
-
10.73
10.69
2.31%
2.16%
1980
11.09
11.52
-
-
10.62
10.69
2.74%
2.24%
1981
11.39
11.48
-
-
10.70
10.68
2.38%
2.32%
1982
11.27
11.44
-
-
10.59
10.68
2.38%
2.41%
1983
11.91
11.39
-
-
10.69
10.68
3.46%
2.49%
1984
11.73
11.35
-
-
10.79
10.67
2.37%
2.58%
1985
11.50
11.31
-
-
10.63
10.67
2.96%
2.68%
1986
11.32
11.27
-
-
10.60
10.67
2.84%
2.77%
1987
11.39
11.23
-
-
10.60
10.66
3.63%
2.87%
1988
11.42
11.18
-
-
10.49
10.66
3.74%
2.97%
1989
11.18
11.14
-
-
10.61
10.66
3.54%
3.07%
1990
10.86
11.10
-
-
10.70
10.65
3.83%
3.17%
1991
11.03
11.06
-
-
10.69
10.65
4.65%
3.28%
1992
11.45
11.02
11.06
10.94
10.71
10.65
4.60%
3.39%
1993
10.55
10.98
10.82
10.95
10.67
10.64
3.58%
3.50%
1994
10.93
10.94
10.95
10.95
10.65
10.57
4.69%
3.61%
1995
10.66
10.90
10.80
10.96
10.45
10.50
3.60%
3.73%
1996
10.98
10.86
10.99
10.97
10.48
10.43
4.08%
3.85%
1997
11.11
10.96
11.12
10.97
10.46
10.47
4.92%
3.97%
1998
11.19
11.06
11.10
10.98
10.52
10.50
4.03%
4.10%
1999
10.77
11.16
10.68
10.99
10.63
10.54
5.29%
4.45%
2000
11.13
11.26
10.98
11.08
10.55
10.57
5.34%
4.82%
2001
10.94
11.36
10.84
11.18
10.57
10.61
5.34%
5.22%
2002
11.39
11.47
11.29
11.28
10.56
10.65
6.33%
5.63%
2003
11.27
11.57
11.05
11.37
10.55
10.68
5.34%
6.07%
2004
11.66
11.68
11.57
11.47
10.71
10.72
5.94%
6.53%
2005
11.84
11.79
11.98
11.57
10.83
10.76
6.67%
7.01%
2006
12.02
11.90
11.73
11.67
10.86
10.79
7.96%
7.50%
2007
12.19
12.00
11.91
11.78
10.85
10.83
7.79%
8.03%
2008
12.29
12.11
11.89
11.88
10.96
10.87
7.92%
8.57%
2009
12.70
12.23
12.23
11.98
10.84
10.91
8.90%
9.13%
2010
12.26
12.34
12.10
12.09
10.99
10.94
8.97%
9.72%
2011
12.21
12.45
12.09
12.19
10.92
10.98
8.73%
10.32%
2012
12.89
12.57
12.48
12.30
11.08
11.02
12.18%
10.95%
2013
12.68
12.68
12.49
12.41
10.91
11.06
12.93%
11.59%
2014
12.84
12.80
12.43
12.52
11.05
11.10
11.55%
12.26%
2015
12.89
12.92
12.53
12.62
11.15
11.13
11.79%
12.94%
2016
12.99
13.03
12.74
12.73
11.23
11.17
12.94%
13.65%
2017
13.02
13.15
12.74
12.85
11.30
11.21
13.64%
14.37%
2018
13.65
13.28
13.28
12.96
11.29
11.25
-
15.11%
2019
13.48
13.40
13.23
13.07
11.27
11.29
-
15.87%
2020
12.92
13.52
12.71
13.19
11.29
11.33
-
16.65%
2021
13.92
13.65
13.54
13.30
11.36
11.36
-
17.44%
2022
13.03
13.77
12.73
13.42
11.22
11.26
-
18.25%
2023
-
-
-
-
11.18
11.16
-
19.07%
Rate of New Cases and Deaths per 100,000: The rate of new cases of pancreatic cancer was 13.8 per 100,000 men and women per year. The death rate was 11.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2018–2022 cases and 2019–2023 deaths.
Lifetime Risk of Developing Cancer: Approximately 1.6 percent of men and women will be diagnosed with pancreatic cancer at some point during their lifetime, based on 2018–2021 data, excluding 2020 due to COVID.
Prevalence of This Cancer: In 2022, there were an estimated 107,988 people living with pancreatic cancer in the United States.
Did You Know? Video Series
Did You Know? Video Series
How Many People Survive 5 Years Or More after Being Diagnosed with Pancreatic Cancer?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
5-Year Relative Survival
13.3%
Based on data from SEER 21 (Excluding IL) 2015–2021. Gray figures represent those who have died from pancreatic cancer. Green figures represent those who have survived 5 years or more.
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. The earlier pancreatic cancer is caught, the better chance a person has of surviving five years after being diagnosed. For pancreatic cancer, 14.6% are diagnosed at the local stage. The 5-year relative survival for localized pancreatic cancer is 43.6%.
Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Pancreatic Cancer
Stage
Percent of Cases
5-Year Relative Survival
Localized Confined to Primary Site
15%
43.6%
Regional Spread to Regional Lymph Nodes
28%
16.7%
Distant Cancer Has Metastasized
51%
3.2%
Unknown Unstaged
6%
11.4%
Percent of Cases by Stage
Localized (15%) Confined to Primary Site
Regional (28%) Spread to Regional Lymph Nodes
Distant (51%) Cancer Has Metastasized
Unknown (6%) Unstaged
5-Year Relative Survival
SEER 21 (Excluding IL) 2015–2021, All Races, Both Sexes by SEER Combined Summary Stage
Compared to other cancers, pancreatic cancer is fairly common.
Rank
Common Types of Cancer
Estimated New Cases 2025
Estimated Deaths 2025
1.
Breast Cancer (Female)
316,950
42,170
2.
Prostate Cancer
313,780
35,770
3.
Lung and Bronchus Cancer
226,650
124,730
4.
Colorectal Cancer
154,270
52,900
5.
Melanoma of the Skin
104,960
8,430
6.
Bladder Cancer
84,870
17,420
7.
Kidney and Renal Pelvis Cancer
80,980
14,510
8.
Non-Hodgkin Lymphoma
80,350
19,390
9.
Uterine Cancer
69,120
13,860
10.
Pancreatic Cancer
67,440
51,980
Pancreatic cancer represents 3.3% of all new cancer cases in the U.S.
3.3%
In 2025, it is estimated that there will be 67,440 new cases of pancreatic cancer and an estimated 51,980 people will die of this disease.
Who Gets This Cancer?
Pancreatic cancer is more common with increasing age and slightly more common in men than women. The rate of new cases of pancreatic cancer was 13.8 per 100,000 men and women per year based on 2018–2022 cases, age-adjusted.
Rate of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Pancreatic Cancer
Males
All Races
15.5
Hispanic
13.3
Non-Hispanic American Indian/Alaska Native
13.8
Non-Hispanic Asian/Pacific Islander
11.3
Non-Hispanic Black
17.9
Non-Hispanic White
16.1
Females
All Races
12.3
Hispanic
11.9
Non-Hispanic American Indian/Alaska Native
11.5
Non-Hispanic Asian/Pacific Islander
9.6
Non-Hispanic Black
15.4
Non-Hispanic White
12.2
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
SEER 21 2018–2022, Age-Adjusted
Percent of New Cases by Age Group: Pancreatic Cancer
Age Range
Percent of New Cases
<20
0.2%
20–34
0.7%
35–44
2.0%
45–54
7.0%
55–64
20.8%
65–74
32.3%
75–84
25.5%
>84
11.5%
Pancreatic cancer is most frequently diagnosed among people aged 65–74.
Median Age At Diagnosis
71
SEER 21 2018–2022, All Races, Both Sexes
Who Dies From This Cancer?
Because survival is poor, the population distribution of people who die of pancreatic cancer is similar to that of people who are diagnosed with the disease. In part because it is difficult to detect early, the average survival time from pancreatic cancer is low. Pancreatic cancer is the third leading cause of cancer death in the United States. The death rate was 11.3 per 100,000 men and women per year based on 2019–2023 deaths, age-adjusted.
Death Rate per 100,000 Persons by Race/Ethnicity & Sex: Pancreatic Cancer
Males
All Races
12.9
Hispanic
9.6
Non-Hispanic American Indian/Alaska Native
10.9
Non-Hispanic Asian/Pacific Islander
8.4
Non-Hispanic Black
15.1
Non-Hispanic White
13.3
Females
All Races
9.9
Hispanic
8.2
Non-Hispanic American Indian/Alaska Native
10.1
Non-Hispanic Asian/Pacific Islander
7.2
Non-Hispanic Black
12.3
Non-Hispanic White
9.9
All Races
Hispanic
Non-Hispanic American Indian/ Alaska Native
Non-Hispanic Asian / Pacific Islander
Non-Hispanic Black
Non-Hispanic White
U.S. 2019–2023, Age-Adjusted
Percent of Deaths by Age Group: Pancreatic Cancer
Age Range
Percent of Deaths
<20
0.0%
20–34
0.1%
35–44
1.0%
45–54
5.1%
55–64
18.5%
65–74
32.2%
75–84
28.8%
>84
14.4%
The percent of pancreatic cancer deaths is highest among people aged 65–74.
Median Age At Death
73
U.S. 2019–2023, All Races, Both Sexes
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new pancreatic cancer cases have been rising on average 0.9% each year over 2013–2022. Age-adjusted death rates have been stable over 2014–2023. 5-year relative survival trends are shown below.
New Cases, Deaths and 5-Year Relative Survival
Rate of New Cases
Death Rate
New cases come from SEER 8. Deaths come from U.S. Mortality. All Races, Both Sexes. Rates are Age-Adjusted. Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software. The 2020 incidence rate is displayed but not used in the fit of the trend line(s). Impact of COVID on SEER Cancer Incidence 2020 data
5-Year Relative Survival
SEER 8 5-Year Relative Survival Percent from 1975–2017, All Races, Both Sexes. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software.
With SEER*Explorer, you can...
Create custom graphs and tables
Download data and images
Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Figure: Anatomy diagram shows the pancreas, liver, bile duct, stomach, gallbladder, duodenum, spleen, colon, and small intestine.
Figure: Pancreas and Nearby Organs
Figure: Anatomy diagram shows the pancreas, liver, bile duct, stomach, gallbladder, duodenum, spleen, colon, and small intestine.
The pancreas is an organ in the abdomen that helps the body digest and use the energy that comes from food. Pancreatic cancer occurs when cells in the pancreas grow out of control and form a growth or tumor. Tumors may be cancerous (malignant) or not cancerous (benign).
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse SEER*Explorer. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in SEER*Explorer. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2025 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.
An official website of the United States government
Localized (15%)
Regional (28%)
Distant (51%)
Unknown (6%)
